Benjamin T. Kopp, MD, is a member of the Section of Pulmonary Medicine and a principal investigator for the Center for Microbial Pathogenesis. Dr. Kopp started one of the country’s few pediatric pulmonary/sickle cell combination clinics to treat sickle cell lung disease in a multidisciplinary clinic. He is also a member of the Cystic Fibrosis Team and an assistant professor of Pediatrics for The Ohio State University College of Medicine.
Dr. Kopp received his undergraduate degree from Miami University, Oxford, Ohio, and went to medical school at The Ohio State University College of Medicine. He completed his residency and fellowship in Pediatric Pulmonology at Nationwide Children’s.
The Kopp laboratory focuses on host-pathogen interactions that impact chronic respiratory diseases such as cystic fibrosis (CF) and lung disease related to sickle cell. The two main areas of this research include macrophage signaling and autophagy and their role in controlling infection as well as biomarkers/pathways of early inflammatory airway disease. Ultimately, the lab is in the process of developing novel therapeutics and targets to allow for improved bacterial killing and regulation of hyper-inflammatory signaling in chronic respiratory diseases.View CV »